A Conversation About the Future of Molecular Diagnostics - 12/31/2010

Why the FDA Should Learn from Itself
Podcast: May 5, 2014 Read More
Zimmer to Acquire Biomet for $13.35B
Deal broadens Zimmer’s offerings in the orthopedic medical device space. Read More
Celgene Pays Nogra Pharma $710M Upfront for Late-Stage Crohn's Disease Drug
Biotech could earn up to $2.6 billion for its oral antisense drug. Read More
FDA Proposes Early Access Pathway for Breakthrough Medical Devices
Agency also clarifies policy on when manufacturers can collect data after approval. Read More
GSK and Novartis Swap Assets in Multi-Billion Dollar Deal
Big Pharmas move toward sector dominance, away from diversification. Read More
Saving U.S. Biomedical Research from Itself
Podcast: April 28, 2014 Read More
Comparative Effectiveness Studies of Cancer Drugs Is Costly
NCI researchers say high cost of some drugs makes it difficult to assess them against cheaper treatments. Read More
Pfizer and AstraZeneca Team with Cancer Research UK to Advance Personalized Medicine
Researchers will have access to pharmas’ drug libraries, testing several drugs at same time in lung cancer trial. Read More
Privately Held Life Sciences Companies Raise $1.5B so Far in April
Biotechs rake in $188 million in series B cash in short week before Easter. Read More
The Rise in Drug Spending and What It Means
Podcast: April 21, 2014 Read More

[Please login to post comments]